Compare BNTC & QNBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | QNBC |
|---|---|---|
| Founded | 1995 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.7M | 281.3M |
| IPO Year | 2020 | 1996 |
| Metric | BNTC | QNBC |
|---|---|---|
| Price | $8.75 | $46.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 174.2K | 23.7K |
| Earning Date | 11-13-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | 6.67 | ★ 21.15 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.00 | $44.75 |
| 52 Week High | $16.76 | $46.60 |
| Indicator | BNTC | QNBC |
|---|---|---|
| Relative Strength Index (RSI) | 42.16 | 55.58 |
| Support Level | $8.52 | $45.60 |
| Resistance Level | $14.09 | $46.60 |
| Average True Range (ATR) | 0.58 | 0.49 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 51.76 | 53.33 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
QNB Corp is a bank holding company based in the United States. It operates through its wholly-owned subsidiary, which engages in the general commercial banking business and offers a full range of banking services to its customers. Its business activities involve attracting deposits and using funds in making commercial loans, residential mortgage loans, consumer loans, and purchasing investment securities. The loan portfolio includes commercial loans, such as commercial and industrial, construction, and loans secured by commercial real estate and residential real estate, and retail loans, including home equity loans and lines, and consumer loans. It generates revenue from net interest income.